Table 1.
Summary of carbohydrate antigen 19-9 assay methods, results, and overall methodological quality of included studies
| Ref. | Number of patient | Assay method | Cut-off for elevated CA19-9 (U/mL) |
Assay results |
Quality score |
||||
| TP | FP | FN | TN | STARD | QUADAS | ||||
| Wang et al[21], 1986 | 58 | RIA | 37 | 20 | 0 | 4 | 34 | 15 | 10 |
| Safi et al[22], 1987 | 191 | RIA | 37 | 80 | 28 | 7 | 76 | 16 | 10 |
| Sakamoto et al[23], 1987 | 57 | RIA | 37 | 26 | 1 | 4 | 26 | 18 | 12 |
| Friess et al[24], 1993 | 154 | ELISA | 37 | 53 | 14 | 6 | 81 | 17 | 11 |
| Röthlin et al[25], 1993 | 97 | RIA | 37 | 54 | 8 | 14 | 21 | 17 | 12 |
| Haglund et al[26], 1994 | 199 | RIA | 37 | 148 | 3 | 31 | 17 | 16 | 11 |
| Kuno et al[27], 1994 | 117 | RIA | 37 | 41 | 10 | 6 | 60 | 19 | 13 |
| Pasquali et al[28], 1994 | 103 | RIA | 37 | 47 | 2 | 11 | 43 | 12 | 9 |
| Satake et al[29], 1994 | 941 | RIA | 37 | 454 | 56 | 118 | 244 | 19 | 13 |
| Hámori et al[30], 1997 | 94 | RIA | 37 | 48 | 4 | 14 | 28 | 11 | 7 |
| Safi et al[31], 1997 | 647 | RIA | 37 | 296 | 48 | 51 | 252 | 18 | 12 |
| Hayakawa et al[32], 1999 | 76 | RIA | 37 | 21 | 14 | 6 | 35 | 16 | 11 |
| Kim et al[33], 1999 | 160 | ELISA | 37 | 69 | 9 | 21 | 61 | 19 | 13 |
| Manes et al[34], 1999 | 58 | RIA | 37 | 30 | 3 | 4 | 21 | 17 | 11 |
| Slesak et al[35], 2000 | 122 | LIA | 37 | 32 | 14 | 14 | 60 | 18 | 12 |
| Maire et al[36], 2002 | 78 | ELISA | 37 | 43 | 4 | 4 | 27 | 17 | 11 |
| Akashi et al[37], 2003 | 46 | RIA | 37 | 15 | 7 | 5 | 19 | 12 | 9 |
| Mu et al[38], 2003 | 24 | RIA | 37 | 4 | 3 | 5 | 12 | 15 | 10 |
| Cwik et al[39], 2004 | 150 | RIA | 37 | 82 | 5 | 16 | 47 | 16 | 11 |
| Jiang et al[40], 2004 | 148 | ELISA | 37 | 82 | 7 | 14 | 45 | 17 | 12 |
| Ventrucci et al[41], 2004 | 81 | EIA | 60 | 45 | 2 | 15 | 19 | 18 | 12 |
| Teich et al[42], 2005 | 59 | ELISA | 22 | 27 | 3 | 3 | 13 | 12 | 9 |
| Chang et al[43], 2007 | 111 | ELISA | 37 | 63 | 11 | 9 | 28 | 18 | 12 |
| ELISA | 100 | 57 | 7 | 15 | 32 | 18 | 12 | ||
| Kuhlmann et al[44], 2007 | 62 | EIA | 37 | 17 | 4 | 11 | 30 | 16 | 11 |
| Liao et al[45], 2007 | 150 | ELISA | 37 | 84 | 15 | 28 | 23 | 15 | 10 |
| Bedi et al[46], 2009 | 84 | ELISA | 37 | 23 | 15 | 11 | 35 | 17 | 12 |
| ELISA | 100 | 14 | 7 | 20 | 43 | 17 | 12 | ||
| Firpo et al[47], 2009 | 107 | ELISA | 37 | 58 | 2 | 17 | 30 | 18 | 12 |
| Liao et al[48], 2009 | 102 | RIA | 37 | 47 | 22 | 11 | 22 | 16 | 10 |
| Morris-Stiff et al[49], 2009 | 188 | ELISA | 37 | 70 | 31 | 3 | 84 | 19 | 13 |
| Talar-Wojnarowska et al[50], 2010 | 157 | ELISA | 37 | 71 | 18 | 14 | 54 | 17 | 12 |
| Zapico-Muñiz et al[51], 2010 | 102 | LIA | 100 | 35 | 7 | 12 | 48 | 16 | 11 |
| Chung et al[52], 2011 | 78 | NR | 30 | 40 | 2 | 15 | 21 | 12 | 9 |
| Gold et al[53], 2013 | 284 | EIA | 37 | 180 | 16 | 54 | 34 | 18 | 11 |
| Kaur et al[54], 2013 | 114 | RIA | 37 | 76 | 9 | 15 | 14 | 17 | 11 |
CA19-9: Carbohydrate antigen 19-9; EIA: Enzyme immunoassay; ELISA: Enzyme-linked immunosorbent assay; FN: False negative; FP: False positive; LIA: Luminescent immunoassay; NR: Not reported; RIA: Radioimmunoassay; TN: True negative; TP: True positive.